MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, NVCT made $1,132K in revenue. -$28,871K in net income. Net profit margin of -2550.44%.

Income Overview

Revenue
$1,132K
Net Income
-$28,871K
Net Profit Margin
-2550.44%
EPS
-$1.32
Unit: Thousand (K) dollars
Revenue Breakdown
    • Finance income

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-12-31
Research and development
18,153
General and administrative
9,421
Operating loss
-27,574
Finance income
1,132
Net loss
-26,442
Effect of warrants modification, see note 6
2,429
Total net loss attributable to common shareholders
-28,871
Basic weighted average number of shares outstanding
21,812,716
Earnings per share, basic
-1.32
Earnings per share, diluted
-1.32
Weighted average number of shares outstanding, diluted
21,812,716
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total net lossattributable to common...-$28,871K Effect of warrantsmodification, see note 6$2,429K Net loss-$26,442K Finance income$1,132K Operating loss-$27,574K General andadministrative$9,421K Research and development$18,153K

Nuvectis Pharma, Inc. (NVCT)

Nuvectis Pharma, Inc. (NVCT)